Cost Effectiveness of N-terminal Pro B-type Natriuretic Peptide for Evaluation and Management of People With Type 2 Diabetes in the Perspective of Brazilian Private Healthcare System.
Saved in:
| Title: | Cost Effectiveness of N-terminal Pro B-type Natriuretic Peptide for Evaluation and Management of People With Type 2 Diabetes in the Perspective of Brazilian Private Healthcare System. |
|---|---|
| Authors: | Lemos G; Access and Medical, Roche Diagnostics Brazil, São Paulo, SP, Brazil. Electronic address: guilherme.lemos@roche.com., Neveux P; Global Access and Policy, Roche Diagnostics International AG, Rotkreuz, Switzerland., Januzzi JL Jr; Baim Institute for Clinical Research, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Pop-Busui R; Department of Medicine, Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health and Science University, Portland, OR, USA., Bolivar Malachias MV; Faculty of Medical Sciences of Minas Gerais, Lucas Machado Educational Foundation, Belo Horizonte, MG, Brazil. |
| Source: | Value in health regional issues [Value Health Reg Issues] 2026 Feb 25; Vol. 55, pp. 101588. Date of Electronic Publication: 2026 Feb 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101592642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-1102 (Electronic) Linking ISSN: 22121099 NLM ISO Abbreviation: Value Health Reg Issues Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
